Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives

The development of peptide-based vaccines for treating human neurodegenerative diseases has been the eventual aim of many research endeavors, although no active immunotherapies have been approved for clinical use till now. A typical example of such endeavors is the effort to develop vaccines for Alz...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassilakopoulou, Vyronia, Karachaliou, Chrysoula-Evangelia, Evangelou, Alexandra, Zikos, Christos, Livaniou, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622585/
https://www.ncbi.nlm.nih.gov/pubmed/34835209
http://dx.doi.org/10.3390/vaccines9111278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622585/
https://www.ncbi.nlm.nih.gov/pubmed/34835209
http://dx.doi.org/10.3390/vaccines9111278

Ejemplares similares